Title: Reversine promotes porcine muscle derived stem cells (PMDSCs) differentiation into female germ-like cells.
Journal: Journal of cellular biochemistry 20121201
Title: The synthetic purine reversine selectively induces cell death of cancer cells.
Journal: Journal of cellular biochemistry 20121001
Title: Preliminary evidence for the dedifferentiation of RAW 264.7 cells into mesenchymal progenitor-like cells by a purine analog.
Journal: Tissue engineering. Part A 20120901
Title: [Research progress of cell dedifferentiation induced by reversine].
Journal: Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery 20120901
Title: Reversine, a 2,6-disubstituted purine, as an anti-cancer agent in differentiated and undifferentiated thyroid cancer cells.
Journal: Pharmaceutical research 20120701
Title: Lead optimization of purine based orally bioavailable Mps1 (TTK) inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20120701
Title: Preferential killing of p53-deficient cancer cells by reversine.
Journal: Cell cycle (Georgetown, Tex.) 20120601
Title: Small molecules that recapitulate the early steps of urodele amphibian limb regeneration and confer multipotency.
Journal: ACS chemical biology 20120420
Title: Characterization of spindle checkpoint kinase Mps1 reveals domain with functional and structural similarities to tetratricopeptide repeat motifs of Bub1 and BubR1 checkpoint kinases.
Journal: The Journal of biological chemistry 20120217
Title: Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy.
Journal: Journal of biomedical science 20120101
Title: Reversin increase the plasticity of bone marrow-derived mesenchymal stem cell for generation of cardiomyocyte in vitro.
Journal: Acta medica Indonesiana 20120101
Title: APC15 drives the turnover of MCC-CDC20 to make the spindle assembly checkpoint responsive to kinetochore attachment.
Journal: Nature cell biology 20110918
Title: Novel chemically defined approach to produce multipotent cells from terminally differentiated tissue syncytia.
Journal: ACS chemical biology 20110617
Title: Aurora B potentiates Mps1 activation to ensure rapid checkpoint establishment at the onset of mitosis.
Journal: Nature communications 20110501
Title: Evidence that Aurora B is implicated in spindle checkpoint signalling independently of error correction.
Journal: The EMBO journal 20110420
Title: Cardiogenol C can induce Mouse Hair Bulge Progenitor Cells to Transdifferentiate into Cardiomyocyte-like Cells.
Journal: Proteome science 20110101
Title: Proteomic definitions of mesenchymal stem cells.
Journal: Stem cells international 20110101
Title: Quantitative mass spectrometry analysis reveals similar substrate consensus motif for human Mps1 kinase and Plk1.
Journal: PloS one 20110101
Title: Uncoordinated loss of chromatid cohesion is a common outcome of extended metaphase arrest.
Journal: PloS one 20110101
Title: A simple guide screw method for intracranial xenograft studies in mice.
Journal: Journal of visualized experiments : JoVE 20110101
Title: Reversine increases multipotent human mesenchymal cells differentiation potential.
Journal: Journal of biological regulators and homeostatic agents 20110101
Title: Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
Journal: Cell death and differentiation 20100801
Title: Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine.
Journal: The Journal of cell biology 20100712
Title: Reversine enhances generation of progenitor-like cells by dedifferentiation of annulus fibrosus cells.
Journal: Tissue engineering. Part A 20100401
Title: Beneficial effects of reversine on in vitro development of miniature pig somatic cell nuclear transfer embryos.
Journal: The Journal of reproduction and development 20100401
Title: Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.
Journal: Nature medicine 20100401
Title: Ontology-based meta-analysis of global collections of high-throughput public data.
Journal: PloS one 20100101
Title: Proteomic signature of reversine-treated murine fibroblasts by 2-D difference gel electrophoresis and MS: possible associations with cell signalling networks.
Journal: Electrophoresis 20090601
Title: The Aurora B kinase activity is required for the maintenance of the differentiated state of murine myoblasts.
Journal: Cell death and differentiation 20090201
Title: Reversine increases the plasticity of lineage-committed cells toward neuroectodermal lineage.
Journal: The Journal of biological chemistry 20090130
Title: Proteomic analysis of blastema formation in regenerating axolotl limbs.
Journal: BMC biology 20090101
Title: Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells.
Journal: Molecular cancer therapeutics 20080501
Title: Induction of growth arrest and polycomb gene expression by reversine allows C2C12 cells to be reprogrammed to various differentiated cell types.
Journal: Proteomics 20071201
Title: The 2,6-disubstituted purine reversine induces growth arrest and polyploidy in human cancer cells.
Journal: International journal of oncology 20071201
Title: Reversine stimulates adipocyte differentiation and downregulates Akt and p70(s6k) signaling pathways in 3T3-L1 cells.
Journal: Biochemical and biophysical research communications 20070629
Title: Reversine inhibits spontaneous synaptic transmission in cultured rat hippocampal neurons.
Journal: Cell biology international 20070601
Title: Detection and functional characterization of Pgp1 (ABCB1) and MRP3 (ABCC3) efflux transporters in the PLHC-1 fish hepatoma cell line.
Journal: Aquatic toxicology (Amsterdam, Netherlands) 20070330
Title: Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle.
Journal: Cell death and differentiation 20061201
Title: Small molecules driving myotube fission.
Journal: Chemistry & biology 20051001
Title: 'Reversine' and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists.
Journal: Journal of medicinal chemistry 20050728
Title: Small molecules, big plans--can low-molecular-weight compounds control human regeneration?
Journal: Angewandte Chemie (International ed. in English) 20040806
Title: Unraveling the molecular basis for regenerative cellular plasticity.
Journal: PLoS biology 20040801
Title: Stem cells from differentiated cells.
Journal: Molecular interventions 20040401
Title: Dedifferentiation? What's next?
Journal: Molecular interventions 20040401
Title: Dedifferentiation of lineage-committed cells by a small molecule.
Journal: Journal of the American Chemical Society 20040121
Title: D'Alise AM, et al. Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells. Mol Cancer Ther. 2008 May;7(5):1140-9.
Title: Qin HX, et al. Synergistic antitumor activity of reversine combined with aspirin in cervical carcinoma in vitro and in vivo. Cytotechnology. 2013 Aug;65(4):643-53.
